Sun Pharma Agrees Not To Sell Generics Of Sleep Aid Lunesta

Law360, New York (April 5, 2013, 3:40 PM EDT) -- A New Jersey federal judge approved a final settlement Thursday in Sunovion Pharmaceuticals Inc.’s patent infringement suit against Sun Pharma Global Inc. over its sleep aid drug Lunesta, a deal that bars Sun Pharma from making or selling a generic version of Lunesta before April 2014.

U.S. District Judge Susan D. Wigenton signed off on the consent judgment and order of permanent injunction between the parties in which Sun Pharma and its subsidiaries Sun Pharmaceutical Industries Inc. and Sun Pharmaceutical Industries Ltd. agreed to put off...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.